The Patent Finder

Terms ending in 2027

Celeniv Pte. Ltd.

Every in-force patent on Celeniv Pte. Ltd.'s record whose computed term ends in 2027, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 10,590,381Composition for Collecting and Preserving Placental Stem Cells and Methods of Using the Composition
In force
 · High confidence
Celeniv Pte. Ltd.In forceHigh confidence
US 8,202,703Placental Stem Cell Populations
In force
 · High confidence
Celeniv Pte. Ltd.In forceHigh confidence
US 9,364,585Methods for Collecting and Using Placenta Cord Blood Stem Cells
In force
 · High confidence
Celeniv Pte. Ltd.In forceHigh confidence
US 10,548,926Methods for Collecting and Using Placenta Cord Blood Stem Cells
In force
 · High confidence
Celeniv Pte. Ltd.In forceHigh confidence
US 8,071,376Production of Oligodendrocytes from Placenta-Derived Stem Cells
In force
 · High confidence
Celeniv Pte. Ltd.In forceHigh confidence
US 8,877,180Human Placental Collagen Compositions, and Methods of Making and Using the Same
In force
 · Low confidence
Celeniv Pte. Ltd.In forceLow confidence
6 of 6 patents shown. Soonest term end first, then patent number.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited